RoffiMPatronoCColletJ-P, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J2015; ehv320.
2.
IbanezBJamesSAgewallS, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the Management of Acute Myocardial Infarction in Patients Presenting with ST-segment Elevation of the European Society of Cardiology (ESC). Eur Heart J2018; 39: 119–177.
3.
MeuneCBalmelliCTwerenboldR, et al. Patients with acute coronary syndrome and normal high-sensitivity troponin. Am J Med2011; 124: 1151–1157.
4.
VafaieMBienerMMuellerM, et al. Analytically false or true positive elevations of high sensitivity cardiac troponin: a systematic approach. Heart2014; 100: 508–514.
5.
BodyRMcDowellGCarleyS, et al. Do risk factors for chronic coronary heart disease help diagnose acute myocardial infarction in the emergency department?Resuscitation2008; 79: 41–45.
6.
FanaroffACRymerJAGoldsteinSA, et al. Does this patient with chest pain have acute coronary syndrome?: the rational clinical examination systematic review. JAMA2015; 314: 1955–1965.
7.
EkbomA.The Swedish Multi-generation Register. Methods Mol Biol2011; 675: 215–220.
8.
NielsenMAnderssonCGerdsTA, et al. Familial clustering of myocardial infarction in first-degree relatives: a nationwide study. Eur Heart J2013; 34: 1198–1203.
9.
MurabitoJMPencinaMJNamB-H, et al. Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. JAMA2005; 294: 3117–3123.
10.
KheraAVEmdinCAKathiresanS.Genetic risk, lifestyle, and coronary artery disease. N Engl J Med2017; 376: 1194–1195.
11.
KheraAVChaffinMAragamKG, et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet2018; 50: 1219–1224.
12.
KheraAVWonH-HPelosoGM, et al. Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia. J Am Coll Cardiol2016; 67: 2578–2589.
13.
DoRStitzielNOWonH-H, et al. Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction. Nature2015; 518: 102–106.
14.
SamaniNJErdmannJHallAS, et al. Genomewide association analysis of coronary artery disease. N Engl J Med2007; 357: 443–453.
15.
NikpayMGoelAWonH-H, et al. A comprehensive 1,000 genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet2015; 47: 1121–1130.
16.
KheraAVChaffinMZekavatSM, et al. Whole-genome sequencing to characterize monogenic and polygenic contributions in patients hospitalized with early-onset myocardial infarction. Circulation2019; 139: 1593–1602.
17.
KheraAVKathiresanS.Genetics of coronary artery disease: discovery, biology and clinical translation. Nat Rev Genet2017; 18: 331–344.
18.
KheraAVEmdinCADrakeI, et al. Genetic risk, adherence to a healthy lifestyle, and coronary disease. N Engl J Med2016; 375: 2349–2358.
